SANUWAVE Health, Inc. (SNWV)
NASDAQ: SNWV · Real-Time Price · USD
6.03
-0.03 (-0.50%)
Aug 5, 2026, 3:17 PM EDT - Market open
SANUWAVE Health Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 10.78 | 11.96 | 10.24 | 1.8 | 1.15 | 0.62 |
Cash & Short-Term Investments | 10.78 | 11.96 | 10.24 | 1.8 | 1.15 | 0.62 |
Cash Growth | 26.80% | 16.82% | 469.67% | 55.85% | 86.27% | -74.60% |
Accounts Receivable | - | - | - | 3.31 | 4.03 | 2.42 |
Inventory | - | - | - | 2.95 | 0.87 | 1.04 |
Other Current Assets | 1.27 | 1.31 | 0.68 | 1.72 | 0.57 | 0.33 |
Total Current Assets | 23.96 | 24.63 | 18.4 | 9.78 | 6.62 | 4.4 |
Net Property, Plant & Equipment | 2.9 | 2.36 | 0.73 | 0.94 | 0.86 | 1.01 |
Other Intangible Assets | 2.92 | 3.03 | 3.73 | 4.43 | 5.14 | 5.84 |
Goodwill | 7.26 | 7.26 | 7.26 | 7.26 | 7.26 | 7.26 |
Other Long-Term Assets | 0.06 | 0.07 | - | - | - | 0.11 |
Total Assets | 37.1 | 37.34 | 30.12 | 22.42 | 19.87 | 18.62 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 3.32 | 3.25 | 3.73 | 5.71 | 4.4 | 7.64 |
Accrued Expenses | 8.61 | 8.41 | 7.76 | 12.11 | 13.35 | 11.45 |
Short-Term Debt | - | - | 25.31 | 29.96 | 38.54 | 24.94 |
Current Portion of Long-Term Debt | 5.59 | 5.64 | - | - | - | - |
Current Portion of Leases | 0.3 | 0.16 | 0.3 | - | - | - |
Unearned Revenue | 0.49 | 0.39 | 0.19 | 0.09 | 0.06 | 0.05 |
Other Current Liabilities | 0.01 | 0.01 | 8.14 | 16.88 | 3.87 | 12.18 |
Total Current Liabilities | 18.3 | 17.85 | 45.42 | 64.76 | 60.22 | 56.26 |
Long-Term Debt | 14.99 | 16.32 | - | - | - | 0.88 |
Long-Term Leases | 1.29 | 0.85 | 0.19 | 0.49 | 0.44 | 0.12 |
Other Long-Term Liabilities | 0.68 | 0.7 | 0.3 | 0.35 | 0.23 | 0.32 |
Total Long-Term Liabilities | 16.96 | 17.88 | 0.49 | 0.84 | 0.67 | 1.31 |
Total Liabilities | 35.26 | 35.72 | 45.91 | 65.59 | 60.88 | 57.58 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0.01 | 0.01 | 0 | 0.55 | 0.48 |
Additional Paid-in Capital | 245.94 | 244.29 | 238.69 | 176.98 | 152.75 | 144.58 |
Accumulated Other Comprehensive Income | 0.01 | 0.01 | 0.01 | -0.11 | -0.07 | -0.07 |
Retained Earnings | -244.12 | -242.69 | -254.5 | -220.05 | -194.24 | -183.95 |
Shareholders' Equity | 1.84 | 1.62 | -15.8 | -43.18 | -41.01 | -38.96 |
Total Liabilities & Equity | 37.1 | 37.34 | 30.12 | 22.42 | 19.87 | 18.62 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 22.16 | 22.97 | 25.8 | 30.45 | 38.98 | 25.93 |
Net Cash (Debt) | -11.39 | -11.01 | -15.56 | -28.66 | -37.82 | -25.32 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.23 | -1.21 | -3.49 | -13.54 | -25.81 | -18.31 |
Book Value | 1.84 | 1.62 | -15.8 | -43.18 | -41.01 | -38.96 |
Book Value Per Share | 0.20 | 0.18 | -3.54 | -20.40 | -27.99 | -28.18 |
Tangible Book Value | -8.34 | -8.67 | -26.79 | -54.87 | -53.41 | -52.06 |
Tangible Book Value Per Share | -0.90 | -0.95 | -6.00 | -25.92 | -36.45 | -37.66 |